Trial · NCT01028014
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG | Pseudoephedrine 120mg ER Daily | -18 | Inter-Quartile Range -108 to 89 | microvolts | |
| Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG | Solifenacin 5mg Daily | 10 | Inter-Quartile Range -56 to 60 | microvolts | |
| Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG | Tamsulosin 0.4mg Daily | 11 | Inter-Quartile Range -102 to 52 | microvolts | |
| Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG | Imipramine 25mg Daily | -15 | Inter-Quartile Range -157 to 75 | microvolts | |
| Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG | Cyclobenzaprine 10mg Daily | 12 | Inter-Quartile Range -71 to 104 | microvolts | |
| Difference (Pre - Post) in Amplitude (Microvolts) of Urethral Sphincter Activity as Measured by Quantitative Concentric Needle EMG | Lactose Capsules, One Daily | 36 | Inter-Quartile Range 23 to 45 | microvolts | |
| Difference (Pre - Post) in Urethral Sensation (Milliamps) as Measured by Current Perception Threshold Testing. | Pseudoephedrine 120mg ER Daily | 0.06 | Inter-Quartile Range 0.0 to 0.68 | Milliamps | |
| Difference (Pre - Post) in Urethral Sensation (Milliamps) as Measured by Current Perception Threshold Testing. | Solifenacin 5mg Daily | 0.06 | Inter-Quartile Range -0.01 to 0.34 | Milliamps | |
| Difference (Pre - Post) in Urethral Sensation (Milliamps) as Measured by Current Perception Threshold Testing. | Tamsulosin 0.4mg Daily | -0.8 | Inter-Quartile Range -0.8 to 0.04 | Milliamps | |
| Difference (Pre - Post) in Urethral Sensation (Milliamps) as Measured by Current Perception Threshold Testing. | Imipramine 25mg Daily | -0.12 | Inter-Quartile Range -0.4 to 0.12 | Milliamps | |
| Difference (Pre - Post) in Urethral Sensation (Milliamps) as Measured by Current Perception Threshold Testing. | Cyclobenzaprine 10mg Daily | 0.0 | Inter-Quartile Range -0.16 to 0.28 | Milliamps | |
| Difference (Pre - Post) in Urethral Sensation (Milliamps) as Measured by Current Perception Threshold Testing. | Lactose Capsules, One Daily | 0.03 | Inter-Quartile Range -0.03 to 0.05 | Milliamps | |
| Difference (Pre - Post) in Maximum Urine Flow Rate (Qmax) (Milliliters Per Second) as Measured by Pressure Flowmetry | Pseudoephedrine 120mg ER Daily | -7.3 | Inter-Quartile Range -23.8 to 7.2 | milliliters per second | |
| Difference (Pre - Post) in Maximum Urine Flow Rate (Qmax) (Milliliters Per Second) as Measured by Pressure Flowmetry | Solifenacin 5mg Daily | 5.0 | Inter-Quartile Range -24.5 to 21.4 | milliliters per second | |
| Difference (Pre - Post) in Maximum Urine Flow Rate (Qmax) (Milliliters Per Second) as Measured by Pressure Flowmetry | Tamsulosin 0.4mg Daily | -5.6 | Inter-Quartile Range -45.3 to 16.5 | milliliters per second | |
| Difference (Pre - Post) in Maximum Urine Flow Rate (Qmax) (Milliliters Per Second) as Measured by Pressure Flowmetry | Imipramine 25mg Daily | -6.6 | Inter-Quartile Range -55.1 to 8.7 | milliliters per second | |
| Difference (Pre - Post) in Maximum Urine Flow Rate (Qmax) (Milliliters Per Second) as Measured by Pressure Flowmetry | Cyclobenzaprine 10mg Daily | 10.3 | Inter-Quartile Range -30.1 to 31.9 | milliliters per second | |
| Difference (Pre - Post) in Maximum Urine Flow Rate (Qmax) (Milliliters Per Second) as Measured by Pressure Flowmetry | Lactose Capsules, One Daily | 10.4 | Inter-Quartile Range -27.6 to 22.8 | milliliters per second |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01028014/results